18 May 2022
Looking at the heart and the brain - What is the role of LAA closure?
Sponsored by Boston Scientific
Anchorperson:
M. Grygier
Moderator:
L. Gheorghe
Summary
Based on a pre-registered case study of a 68-year-old male patient, DG, who presented with atrial fibrillation, intracranial bleeding on warfarin, and compartment syndrome secondary to bleeding from warfarin, this EuroPCR 2022 session will allow you to discuss the challenges of treating AF patients with previous intracranial bleed, understand the role and functioning of a heart-brain team, and showcase the safety of Watchman FLX in specific subsets of patients.
Learning Objectives
- To discuss the challenges of treating atrial fibrillation patients with previous intracranial bleed
- To understand the role and functioning of a heart-brain team
- To showcase the safety of Watchman FLX in specific subsets of patients
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)